✦ LIBER ✦

PMH17: LONG-TERM ECONOMIC BENEFITS OF ANTIPSYCHOTIC USE

✍ Scribed by AN Boscoe; RE White; SC Bolge

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH65 EFFECT OF PRIOR AUTHORIZATION ON A

✍ JM Paterson; S Bronskill; J Sutherland; L Warren; K Sykora; K Bassett; GM Anders 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PMH17 OUTCOME TRAJECTORIES IN THE LONG-T

✍ D Milton; G Cuyun Carter; D Faries; H Ascher-Svanum 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PMH34 Long-Term Cost-Effectiveness of At

✍ K. Rajagopalan; K. O'Day; K. Meyer; A.A. Pikalov iii; A. Loebel 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PMH22 CLINICAL AND ECONOMIC CONSEQUENCES

✍ A. Berger; J. Edelsberg; M. Treglia; J. Alvir; G. Oster 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Long-term Use of Atypical Antipsychotics

✍ Megan J. Ehret; Gary M. Levin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

Neurobiologically-based earning benefits

✍ James McGregor; Manuk Barseghyan 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 107 KB